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ABSTRACT 
 
Introduction  
Ano-genital warts affect at least 30 million people worldwide. Ano-genital warts are caused 
by low risk Human Papilloma virus infections in 90% of cases. In African populations the 
ano-genital warts have not been adequately investigated thus our main goal was to highlight 
the factors associated with the occurrence of ano-genital warts among HIV infected 
individuals. Studies in both men and women have shown that the likelihood of getting ano-
genital warts is significantly increased when one is infected with HIV hence the need to 
investigate in this population. More over data suggests that HPV infection occur more 
frequently among HIV infected individuals because of the HIV associated CD4+ T-cell 
immune-suppression. 
Methods 
 We conducted an analytical cross sectional study of routinely collected secondary medical 
data from Ward 21 ART clinic at the Hillbrow community centre in Hillbrow Johannesburg 
central. Our study participants were all HIV infected patients 16 years and older who 
attended the ART clinic between 01 January 2009 and 31 December 2011 and were recorded 
in the therapy edge database. Our outcome was clinically diagnosed ano-genital warts. We 
analysed data using the Chi squared test or Fischers exact test to make comparisons in 
bivariate analysis. Logistic regression was used to assess factors associated with ano-genital 
warts. Factors assessed were other STIs namely syphilis, herpes simplex virus type 2 and 
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scabies as well as age, gender, first CD4 and employment status and ART status of a patient.  
The Models were assessed using the linktest and the Hosmer Lemeshow goodness of fit test. 
 
Results 
Ano-genital warts (AGWs) prevalence was 4% (251 out of 6634) among females and 3% 
(118 out 4116) among males. Prevalence of AGWs in both females and males decreased with 
increasing age. In females the prevalence was between 1% and 8% and in males it was 
between 1% and 4%. The odds of having ano-genital warts among females if one was above 
25 years ranged from 1.6 to 18.3,  showing an upward trend. Among females a CD4 count of 
less than 200 cells/ml3 was also associated with ano-genital warts occurrence, OR 1.32(1.02 - 
1.72). Among males the odds of having ano-genital warts if one was not on ART were 1.53 
(1.01 – 2.31) times when compared to those who were on ART. 
Discussion and Conclusion 
Prevalence of genital warts was highest among the younger age groups in both males and 
females and it decreased with increasing age consistent with literature. Age was strongly 
associated with ano-genital warts and the association became stronger with increasing age 
among females while no association was found among males. In line with findings from 
other studies we found low CD4 count of ≤ 200 cells/m3 to be associated with ano-genital 
warts in HIV positive females; however it was a weak association. Among males a weak 
association between ART status and ano-genital warts was established and none in females. 
This is consistent with the fact that in the post ART era there has been no substantial decline 
in HPV infections.  
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Definition of terms 
 
 Aetiology: It refers to the study of the causes of a disease and the factors underlying their 
spread.  
Baseline: A measurement used as a basis for comparison. 
Condylomata acuminata: these are benign proliferation of the ano-genital skin and mucosa 
resulting from Human Papillomavirus (HPV) infection. 
CD4 count: A measure of the number of helper T cells per cubic millimetre of blood, used to 
analyze the prognosis of patients infected with HIV. 
Epidemiology: It is the study of the distribution and the determinants of health related states 
and events (including disease), and the application of the study to the control of diseases and 
other health problems. 
Dichotomous: divided into two classifications or parts. 
Genotype: The genetic constitution of an individual organism. 
Incidence: The occurrence, rate of frequency of a disease. It is the number of new cases per 
population at risk that develop during a specific time period. 
Prevalence: The total number of cases of a disease in a given population at a specific time 
and place. 
Proxy: A variable that is used in place of the variable of interest (the inferred variable) that 
has a close correlation with the inferred variable. 
 
Therapy Edge database: It is a web based decision support system used for the treatment of 
HIV.
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1 INTRODUCTION 
 
1.1 Background 
Ano-genital warts which are also known as condylomata acuminata affects at least 30 million 
individuals worldwide (1).  These are benign proliferation of the ano-genital skin and mucosa 
resulting from Human Papillomavirus (HPV) infection (1). HPV infection is the most 
common sexually transmitted infection (STI) (1-4). Infection is highest in the young sexually 
active population and declines significantly after age of reproduction (1, 5, 6). More than 100 
HPV genotypes have been identified (7, 8). The genotypes are classified as either high risk or 
low risk depending on their association with malignant lesions of the cervix (7). Low risk 
HPV genotypes are associated with benign skin lesions and have been linked to 90% of ano-
genital warts infections (7, 9).  
 According to a systematic review conducted by Banura et al, studies have found prevalence 
rates of AGWs among sex workers and women with STIs in Central and South African 
regions to range from 0.2% to 14% (10). The age range for these women lies between 14 and 
65 years (10).  Few studies have reported on the prevalence of AGWs among men in Africa 
(10, 11). In those studies where AGWs have been reported, the prevalence among sexually 
active men 18 years and older ,was found to range between 4.8% and 50.5% in central and 
south African regions (10).   
Infections with HPV have been found to be prevalent among men attending sexual Health 
clinics in South Africa (12). HPV 6, 11, 16 and 18 have been found to be the most prevalent 
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either single or combined, with HPV 6 and 11 found to be significantly higher among those 
with AGWs (12). HPV/HIV co-infection is twofold higher and is associated with reduced 
HPV viral clearance due to impaired immunity (13). Ano-genital warts occur more 
frequently in women who are HIV infected especially those with low CD4 count (2), but 
some studies indicate that ano-genital warts affect both men and women equally (1, 14). This 
apparent higher incidence in women could be due to the fact that women tend to seek 
medical care more than men do (1). A study in Burkina Faso showed that genital warts were 
more prevalent among HIV infected women (7%) compared to uninfected women (1.6%). 
The association of other STIs with ano-genital warts is still poorly understood. The data 
available is uncertain and predominately from western populations (2).The impact of 
antiretroviral treatment on the occurrence of ano-genital warts remains uncertain with 
varying results on its incidence and persistence being obtained from different statistical 
designs (2). 
 
 
1.2 Problem Statement 
 Literature shows that in African populations the incidence and prevalence of low risk-HPV 
and ano-genital warts are not well known, little is known about their epidemiology and 
natural history (3-5). Although ano-genital warts are the most common clinical lesions 
caused by HPV, they have not been adequately described (15).  They have been 
overshadowed by the more life threatening cervical cancer. Previous and recurring ano-
genital warts have been shown to be associated with multiple HPV-DNA infections leading 
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to the development of squamous intraepithelial lesions (16).Both HIV and HPV infections 
are prevalent in Sub- Saharan Africa.  HIV infection when present is likely to increase 
transmission and acquisition of HPV as well as the development of clinically evident ano-
genital warts (17). Those with ano-genital warts are likely to experience prolonged episodes 
exacerbated by a suppressed immune system (2). Current data suggest the need for better 
ano-genital warts data collection and surveillance especially in Africa (18). 
 The psycho-social and economic effects of ano-genital warts are quite substantial (19). They 
have a huge impact on health services and the individual patient (20). The presence of ano-
genital warts impacts heavily on the quality of life of those with the disease causing extreme 
discomfort and embarrassment for most sufferers. The psychological stress associated with 
having the disease is often greater than the morbidity (21). 
In this study we want to highlight the burden of ano-genital warts amongst HIV infected 
individuals at a Hillbrow clinic in Johannesburg, as well as the factors associated with their 
occurrence. The study will add to the body of knowledge on the occurrence of AGWs in   the 
South African population.   
 
1.3 Justification 
In South Africa and the rest of Sub-Saharan Africa the incidence and prevalence of ano-
genital warts is poorly described more so among males. Despite the paucity of data, ano-
genital warts pose a substantial financial and medical burden on health services. In addition 
they also affect the quality of life of those infected, causing increased morbidity. Although 
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ano-genital warts are benign tumours caused by HPV type 6 and/or 11, co-infection with 
HIV has been found to result in multiple HPV infections (12).  
 
1.4 Literature Review 
1.4.1  Aetiology of Ano-genital warts  
Ano-enital warts also known as condylomata acuminata affect at least 30 million individuals 
worldwide (1). These are benign proliferation of the ano-genital skin and mucosa resulting 
from Human Papillomavirus (HPV) infection (1). HPV is a highly contagious virus (9). 
Transmission of HPV is predominately through sexual contact with an infected person (9, 22). 
Additionally, sexual contact with an infected individual results in a 75% chance of 
contracting HPV (1, 9). In rare cases vertical transmission has been reported (9, 22). The 
Centre for disease control and prevention estimates that 50% of all sexually active 
individuals will acquire HPV infection at some point in their lives (9, 23) and at least 80% of 
women will have acquired it by the age of 50 (23). Infection is highest among young women 
of ages 20 to 24. (1, 22).  
Genital warts are the most frequent of benign tumours occurring in the ano-genital region and 
approximately 90% of the genital warts are associated with low risk HPV type 6 and 11 (7, 9, 
24). The lesions present as flesh coloured lesions on the external genitalia and are only 
clinically diagnosed, they usually develop 2-3 months after infection with HPV (typically 6 
and 11) (25). However infection with HPV 6 and 11 does not always result in the occurrence 
of genital warts (25). 
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1.4.2  Risk Factors for Ano-genital Warts infection 
Several studies have attributed the occurrence of ano-genital warts to the following risk 
factors; early age at first sex, increase in the total number of sexual partners, unprotected 
sexual intercourse, use of oral contraceptives, a history of sexually transmitted infections,  
smoking and immune-suppression (9, 21-22, 26).  In addition to the factors already 
mentioned older age has been found be associated with the persistence and/or recurrence of 
ano-genital warts (18).  
Other studies have found a history of other STIs to be associated with the occurrence of ano-
genital warts (18, 22). It must be noted that the association of other STIs with ano-genital 
warts is still poorly understood. These data are uncertain and predominately from western 
populations (2). 
The impact of antiretroviral treatment on the occurrence of ano-genital warts remains 
uncertain with varying results on its incidence and persistence being obtained from different 
statistical designs (2). 
  
1.4.3  Ano-Genital Warts and HIV infection 
Data suggests that HPV infection occur more frequently among HIV infected women 
because of the HIV associated CD4+ T-cell immune-suppression (27). In those who are co-
infected with HIV and HPV, HIV infection may facilitate the development of clinically 
evident ano-genital warts (17).  Studies in both men and women have shown that the 
likelihood of getting ano-genital warts is significantly increased when one is infected with 
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HIV (12, 17, 28). In HIV infected women the likelihood of developing ano-genital warts is 8 
times greater than in HIV uninfected women (17).    
A study in Burkina Faso showed that genital warts were more prevalent among HIV infected 
women (7%) compared to uninfected women (1.6%). High prevalence of genital warts is 
associated with low CD4 count (nadir CD4+ count ≤200 cells/μL) (2). 
Data on ano-genital warts is scarce from sub-Saharan Africa and South Africa, confirming 
the view that little is known on the epidemiology and natural history of ano-genital warts in 
this region. We believe this area of study has received inadequate attention. Many studies 
focus on HPV infection in association with the occurrence of cancerous tumours. 
 
1.5 Study Objectives 
1.5.1 Research Question 
What are the factors associated with ano-genital warts among HIV infected patients at a 
Hillbrow clinic in Gauteng South Africa during the period 1 January 2009 to 31 December 
2011? 
1.5.2 Objectives 
1. To describe the demographic distribution of HIV infected patients in a Wits 
Reproductive health Institute (WRHI) supported clinic in Gauteng South Africa 
from 1 January 2009 to 31 December 2011. 
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2. To determine the prevalence of ano-genital warts among HIV infected patients 
in a WRHI supported clinic in Gauteng South Africa from 1 January 2009 to 31 
December 2011. 
3. To determine the factors associated with ano-genital warts among male and 
female HIV infected patients in a WRHI supported clinic in Gauteng South Africa 
from 1 January 2009 to 31 December 2011. 
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2 MATERIALS AND METHODS 
This chapter reviews the methods used in the study and includes procedures taken to ensure 
validity of results. A description of data analysis is given and it includes the statistical 
methods that were used for model assessment and validation. 
2.1  Study Design 
This study used an analytical cross-sectional design utilising secondary data collected 
routinely in the WRHI supported clinic. Only the first occurrence of a condition or disease 
within the study period for all study participants was used in analysis. The study period was 
from 1 January 2009 to 31 December 2011.  
  
2.2  Study population and setting 
The study population consisted of HIV infected patients attending Ward 21 clinic in   
Hillbrow which is a WRHI supported clinic in Gauteng from 1 January 2009 to 31 December 
2011. This clinic is part of the Hillbrow Community Health Centre (29) situated in central 
Johannesburg. It is the largest non-hospital antiretroviral therapy initiation site in the world 
and sees over 4000 patients every month (29).  
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2.3 Study Sample 
2.3.1 Inclusion criteria 
All patients above the age of 16 who were entered into the Therapy EdgeTM database during 
the study period were eligible for inclusion. (Therapy EdgeTM database is a support system 
used for the treatment of HIV). It is used to capture a patient’s clinical information. The 
information captured typically included medical conditions, medications and treatment 
options. 
Only those study participants with data on most of the exposures of interest which were other 
STIs namely syphilis, herpes simplex virus type 2 and scabies as well as age, gender, first 
CD4 and employment status and ART status of a patient under study were included. 
2.3.2 Exclusion criteria 
· Patients enrolled at the clinic outside of the study period were excluded. 
· Study participants missing data on more than two exposures of interest were also 
excluded. The exposures of interest looked at were other STIs namely syphilis, herpes 
simplex virus type 2 and scabies as well as age, gender, first CD4 and employment 
status and ART status of a patient 
2.3.3 Sample Size 
Patients enrolled in the Therapy EdgeTM database for the clinic during the study period were a 
total of 19 099. All these participants were eligible to form the study sample. However, all 
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those patients with missing data on more than two exposures of interest were dropped from 
further analysis as well as those younger than 16 years. Of the 19 099 patients 8 006 did not 
have any clinical conditions or infections recorded and 343 were younger than 16. The final 
sample size of the study participants who were included in analysis was 10 750, (4 116 males 
and 6 634 females).  
2.4 Measurements 
The outcome variable in the study was ano-genital warts clinically diagnosed as explained in 
the table below. The outcome was a dichotomous variable with patients either having ano-
genital warts or not. Explanatory variables that were evaluated for association with the 
outcome variable are listed and explained in the table below. 
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Table2-1 Variables used in the study and their explanations. 
 
2.5  Data management 
2.5.1 Data Collection and processing 
The data was routinely collected by the clinic for HIV management of patients. The clinic 
employs Therapy EdgeTM database to capture medical information of patients. Therapy 
EdgeTM was first introduced in the clinic in 2009. The data was transcribed into the Therapy 
EdgeTM database by trained data capturers. This data was then imported from Therapy 
EdgeTM database to Stata Statistical Software: Release 11. (StataCorp LP. 2007.College 
O
ut
co
m
e 
va
ri
ab
le
  
 Ano-genital warts clinically diagnosed by a trained registered clinician. 
E
xp
la
na
to
ry
 v
ar
ia
bl
es
 e
va
lu
at
e 
ART treatment- stratified as being on ART or not. Generated using regimens of patients. 
All patients without a regimen were taken to be not on ART.  
Infection with herpes simplex 2- evidence of herpetic flare/occurrence  during the study 
period 
Infection with syphilis  - presentation of syphilitic lesion recorded during the study period 
Infection with scabies - taken to be the an episode of scabies recorded during the study 
period   
Concurrence with cervical cancer(females only) 
Age – Categorised into age groups so that inferences can be made in group of individuals 
in each particular age group 
Employment status - as proxy for Income/socioeconomic status 
CD4 count- genital warts have been found to occur more frequently and persistently in 
individuals with low CD4 count. Low CD4 considered to be that below 200 
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Station, Texas) for analysis. Patient demographic information such as sex, age and 
nationality among others was collected when a patient first visited the clinic. A patient’s first 
CD4 count was also taken and recorded on their first visit to the clinic. A patient was then 
monitored and all conditions that a person suffered from recorded with each subsequent visit. 
Periodically the patients CD4 count was taken and recorded. Upon initiation on ART the last 
CD4 count that was taken before initiation was taken to be the baseline CD4 count of the 
patient. Data were cleaned and validated by the data capturers on a continuous basis. 
2.5.2 Data Analysis  
Individual datasets of clinical conditions, patient demographic information and clinical ART 
were merged to form one dataset. New variables for the different sexually transmitted 
illnesses were generated, including the outcome variable ano-genital warts. Age which is a 
continuous variable was recoded into age group categories. According to literature, HPV 
infection is highest in the young sexually active population of ages below 25, and above the 
age of 55 HPV infection drops significantly (1, 5, 6, 22). CD4 count was also recoded into a 
dichotomous variable with CD4 lower than or equal to 200 considered as low. A CD4 count 
of 200cells/mm3 was the CD4 count at which a patient became eligible for ART initiation in 
South Africa during the data collection period (30).  ART status of patients was determined 
using the current regimen of patients as a proxy. Approximately 50% of patients were 
missing data on their ART status hence regimen status was used as proxy. Those not on any 
regimens were taken as being not on treatment. The employment status of a patient was 
categorised as employed, unemployed, student and other (referring to all individuals on some 
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form of grant) and missing which referred to those with missing status.  The level of 
significance used for all tests was 5%. 
2.5.2.1 Descriptive Statistics 
 Frequency of socio-demographic and clinical factors across the study population was 
determined and presented using bar graphs and tables. All variables were described using 
proportions and percentages. The Chi squared test or Fisher’s Exact test where Chi-Square 
was invalid was used to make comparisons between those who have ano-genital warts and 
those without ano-genital warts.  
 
2.5.2.2 Inferential statistics 
The outcome variable in the study was dichotomous, being the presence or absence of ano-
genital warts therefore logistic regression was used in analysis. Univariate Logistic 
Regression and multivariable logistic regression models were used to calculate crude 
(unadjusted) odds ratios and adjusted odds ratios respectively to determine factors associated 
with genital warts in the study.  
2.5.2.3 Confounding and effect modification in the study 
Epidemiology of genital warts has been found to differ significantly in males and females. 
Also other studies evaluated in the literature review were per each gender. As such 
confounding and effect modification by gender was independently assessed and gender 
stratified analysis was conducted. The algorithm below was used to determine if confounding 
and/or effect modification by gender exists. 
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                                    Stratify by confounder and calculate OR for each stratum 
 
 
 
 
 
·  
 
 
 
 
Algorithm to determine confounding and effect modification 
 
2.5.2.4 Model Assessment and Validation 
The different models in multivariable analysis were compared using the likelihood ratio test 
and the model that best fit the data was accepted as the best model. All our models where 
assessed for validity using the linktest and the Hosmer and Lemeshow’s goodness of fit tests. 
The Linktest checks the model for any specification error.  If a model is correctly specified 
we do not expect to have any additional predictors that are statistically significant except by 
chance (31). The linktest has its limits hence it was used in conjunction with another tool to 
check model validity, the Hosmer and Lemeshow’s goodness of fit test.  
 
Crude OR 
Stratum-Specific OR similar 
but different from crude 
Confounding only exists 
(control for confounding) 
Stratum-Specific OR different 
and also different from crude 
Effect modification 
 
Stratum-Specific OR similar and 
also similar to crude 
No confounding or effect 
modification 
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2.6 Ethical Considerations 
The letter of permission to use the data was obtained from WRHI (appendix C). Ethical 
clearance was obtained from the university of Witwatersrand research ethics committee 
(Clearance Certificate number M120939). Study participants were identified using unique 
identifiers and no personal identifying information was on the dataset. The study was 
secondary analysis therefore informed consent from individuals was not sought.  
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3 RESULTS 
 
This section outlines all the results of the analyses done in the study. The first section 
describes the study population in terms of gender and age. The second section describes the 
distribution of ano-genital warts in the study population. The third section gives the results of 
the evaluation of factors associated with genital warts with an assessment of confounding and 
effect modification by gender. 
 
 
3.1 Description of the population under study 
3.1.1 Distribution of gender in the study population 
The final study sample consisted of a total of 10750 patients, of which 63% were females and 
37% were males as shown in figure 3.1. 
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Figure 3.1 Percentage of each gender as a proportion of the whole study sample 
 
 
3.1.2 Distribution of each gender in the study by age 
 
 
 
Figure 3.2. Description of gender by age group in the study sample 
 
According to figure 3.2 above in all age groups except for those older than 55 years there 
were more females attending the clinic than males for ART care. In general more females 
patronized the clinic when compared to males during the period January 2009 to December 
2011. 
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3.2 Description of the occurrence of ano-genital warts 
(Prevalence) in the study population  
 
A total of 369 (3%) patients had at least one episode of ano-genital warts during the study 
period. Figure 3.3 shows that 68 % of these were females and 32% were males. 
 
   
Figure 3.3.  Distribution of genital warts among the study participants  
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3.2.1 Prevalence of ano-genital warts in the study population 
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Figure3.4. Prevalence of ano-genital warts among the patients in the study sample. 
 
 
The overall prevalence of genital warts in the study was 3%. Prevalence was 4% among 
females and 3% among males.  Figure 3.4 above shows that the prevalence was highest in the 
16 – 25 year age group and decreased with increasing age. Table 3.1 below shows no 
significant differences between those with anogenital warts and those without ano-genital 
warts with regards to scabies, herpes simplex 2, syphilis, and ART status. Differences were 
detected with employment status (p-value 0.047), age (p-value <0.0001) and gender (p-value 
<0.011).  
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 Table 3-1 Prevalence of ano-genital warts and tests for differences in the study sample  
Explanatory variable    No anogenital 
Warts (%) 
Anogenital 
Warts (%) 
p-values (0.05 level of 
significance) 
Gender :  Male 
              Female 
97.13 
96.22 
2.87 
3.78 
       0.011 
Age categories:  
 16-25 
26- 35 
 36- 45 
 46- 55 
>55 
 
 93.03 
95.90 
97.01 
98.83 
99.65 
 
6.97 
4.10 
2.99 
1.17 
0.35 
< 0.001 
Scabies              : yes 
                           : no 
95.24 
96.57 
4.76 
3.43 
0.635 
Herpes Simplex 2       : yes 
                                     : no 
96.19 
96.58 
3.81 
3.42 
0.682 
Syphilis              : yes 
                           : no 
93.75 
96.58 
6.25 
3.42 
0.283 
ART                : yes 
                         : no 
96.46 
96.73 
3.54 
3.27 
0.442 
Employment status: 
Employed 
Unemployed 
Student 
Other 
Missing 
 
96.61 
96.19 
92.31 
100.00 
97.37 
 
3.39 
3.81 
7.69 
0.00   
2.63 
0.047 
CD4 count  : <200 cells/ml3 
                     >200 cells/ml3 
96.38 
96.69 
3.62 
3.31 
0.388 
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Figure 3.5. Prevalence of ano-genital warts in males and females by age group in the 
study sample 
 
 
In figure 3.5 above, prevalence was highest among the 16 – 25 year age group for both sexes 
and decreased with increasing age for both sexes. Between the ages of 16 and 25 as well as 
age group 26-35 prevalence was higher in females (8% and 5% respectively) than males (4% 
and 3% respectively). In the age group 36 to 45 the prevalence was similar between males 
(3%) and females (3%). Above the age of 46, prevalence was (0.7%) among males and 
among females it was (0%). (See also table 3.2 below). 
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Table 3-2 Prevalence of ano-genital warts and tests for differences between those who 
have genital warts and those without genital warts in each gender 
 
 FEMALES 
Prevalence 3.78% 
MALES  
Prevalence 2.87% 
Explanatory variable No Genital 
Warts (%) 
 Genital 
Warts 
(%) 
p-values (0.05 
level of 
significance) 
 No Genital 
Warts (%) 
 Genital 
Warts (%) 
p-values (0.05 
level of 
significance) 
Age categories:  
  <=25 
26- 35 
 36- 45 
 46- 55 
>55 
 
92.44 
95.51 
97.04 
99.10 
100 
 
7.56 
4.49 
2.96   
0.90   
0 
 
<0.001* 
 
95.73 
96.74 
96.97 
98.49 
99.32 
 
4.27 
3.26 
3.03 
1.51 
0.68 
 
0.073* 
Cervical Cancer: yes 
                            : no 
100 
96.21 
0 
3.79 
1.00 - -  
Scabies              : yes 
                           : no 
93.10 
96.23 
6.90 
3.77 
0.379 100 
97.12 
0 
2.88 
1.000 
Herpes Simplex 2  : yes 
                                : no 
97.10 
96.19 
2.90 
3.81 
0.498 95.00 
97.22 
5.00 
2.78 
0.099 
Syphilis              : yes 
                            : no 
93.33 
96.23  
6.67 
3.77   
0.407 94.44 
97.14 
5.56 
2.86 
0.408 
ART                   : yes 
                            : no 
96.32 
96.06 
3.68 
3.94 
0.577 96.67 
97.89 
3.33 
2.11 
0.022* 
Employment status 
Employed 
Unemployed 
Student 
Other 
Missing 
 
96.31 
95.88 
90.00 
100 
96.96 
 
3.69 
4.12 
10.00 
0 
3.04 
 
0.097 
 
 
3.01 
3.18   
0 
0 
1.95 
 
96.99 
96.82 
100 
100 
98.05 
 
0.49 
CD4 count  : >200 
                      ≤200 
95.75 
96.67 
4.25 
3.33 
0.056 97.36 
96.73 
2.64 
3.27   
0.239 
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Among females significant differences were detected between groups for age (p value of 
<0.0001) and CD4 count showed border line significance (p value 0.056). Employment status 
showed a p value of 0.097 therefore there was no significant association. There were no 
individuals among those with cervical cancer who had ano-genital warts. No significant 
differences were detected as well for scabies, herpes simplex 2, syphilis, and ART status. 
Among males significant differences were detected for ART status (p value of 0.022).  
Age and herpes simplex 2 had p values of 0.073 and 0.099 respectively and these were not 
significant. There were also no significant differences detected for scabies, syphilis, and CD4 
count. 
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3.3 Univariate and Multivariate Analysis with assessment of 
confounding and effect modification by gender 
 
3.3.1 Assessment of Confounding and effect modification by gender 
 
Analysis was conducted to assess the effect of gender (table 3.3) on the relationships of other 
explanatory variables with the occurrence of ano-genital warts.  For scabies, herpes simplex 
2 and syphilis there was no confounding or effect modification by gender present. Univariate 
analysis before and after adjusting for gender as well as after stratification did not indicate a 
10% difference which indicates the presence of confounding or effect modification. For the 
variables CD4 and ART status the assessment of the interaction with gender was significant. 
There was no difference in the crude and adjusted odds ratios indicating that there was no 
confounding by gender. After stratification the stratified odds ratios were significantly 
different from each other and from the crude. This indicated that gender was modifying the 
relationships of these variables with the occurrence of ano-genital warts. Therefore males and 
females were analysed separately. 
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Table 3-3 Results of the assessment of confounding and effect modification by gender 
 Crude Adjusted for Gender Stratified by Gender Interaction 
result 
Decision 
 OR 95% CI OR 95% CI Males 95% CI Females 95% CI   
Scabies 1.41 0.34 – 5.86 1.38 0.33 – 5.74 - - 1.89 0.45 -   8.0 Not significant No effect 
Syphilis 1.88 0.58  - 6.09 1.88 0.58 – 6.08 2.00 0.26 – 15.16 1.82 0.43 -7.10 Not significant No effect 
           
CD4 1.1 0.89 – 1.36 1.1 0.89 – 1.36 0.80 0.55 – 1.16 1.29 0.00 – 1.68 Significant Effect modification 
ART treatment 1.09 0.88  - 1.35 1.09 0.88   -  1.36 1.60 1.07 – 2.41 0.93 0.72 – 1.20 Significant Effect modification 
Age: 
16-24 
          
26 – 35 1.75 1.25 – 2.45 1.71 1.22 – 2.4 1.32 0.52 – 3.39 1.74 1.21 – 2.50   
36 – 45 2.43 1.71  - 3.46 2.32 1.62 – 3.33 1.43 0.56 – 3.64 2.68 1.79 – 4.03   
46 – 55 6.31 3.44 - 11.59 6.06 3.29 – 11.15 2.90 0.93 – 9.05 8.98 3.78 – 21.36 Not significant Confounding 
>55 21.34 2.93 – 155.6 20.23 2.77 – 147.7 6.56 0.76 – 56.96 - -   
Employment status: 
Employed 
          
Unemployed 0.88 
 
0.71 – 1.11 
 
0.91 
 
0.73 – 1.14 
 
0.94 0.63 – 1.40 0.89 0.68 – 1.18   
Student 0.42 
 
0.17 – 1.06 
 
0.44 
 
0.18 – 1.12 
 
- - 0.34 0.13 – 0.88   
Other - - -  - - - -   
Not indicated/Missing 1.29 0.94 – 1.79 1.32 0.95 – 1.82     Not significant No effect 
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3.3.2 Univariate and Mutivariable Analysis to assess factors associated 
with ano-genital warts ocurrence  
Univariate and multivariate analysis was done to assess factors associated with the 
occurrence of ano- genital warts for each gender and the results are presented below. 
 
3.3.2.1 Univariate and multivariable analysis for females 
In table 3.4 no associations with ano-genital warts occurrence was observed in both 
univariate and multivariate analysis for scabies, herpes simplex 2, syphilis, ART status and 
employment status amongst females in this study group. CD4 count was found to be weakly 
associated with ano-genital warts occurrence after adjusting for confounding, OR of 
1.32(1.02 – 1.72). Age was strongly associated with ano-genital warts occurrence before and 
after adjusting for confounding. The strength of the association increased with increasing 
age, OR of 1.65(1.13 - 2.41) for those aged between 26 and 35 years, 2.59(1.69 – 3.59) for 
those aged 36 to 45 years, and 8.45(3.52 - 20.15) for those aged 46 to 55 years. A likelihood 
ratio testing the expanded age variable (categorical) model against the reduced age variable 
model was done to check for a linear trend. The null hypothesis in this instance was that the 
reduced model is equal to the expanded model. The p value of 0.24 was greater than 0.05 
thus we did not reject the null hypothesis but concluded that there is a linear trend as the 
reduced model was not different from the expanded model.  
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Three models were compared using the likelihood ratio test to find the model that was the 
best fit for the data. A reduced model with variables CD4 count and age proved to be the best 
fit with a chi square statistic of 3.41 which was statistically insignificant (p value of 0.54). 
This model was tested for errors using the linktest and the Hosmer-Lemeshow test for 
goodness of fit. The Hosmer-Lemeshow test yielded a large p value of 0.92. Both tests 
indicated that the model fit the data well.  
 
Table 3-4 Univariate and Multivariable analysis for females  
 
Explanatory variable Crude OR   95% CI Adjusted OR 95% CI  
Scabies 1.89 0.45 -   8.0   
Herpes Simplex 2         0.75 0.33   - 1.71   
Syphilis 1.82 0.43  -  7.10   
CD4 count   1.29 0.99   - 1.68 1.32 1.02  -  1.72 
ART status   0.93 0.72  -  1.20   
Age categories:  
 16 -25 
26- 35 
 36- 45 
 46- 55 
>55 
 
1 
1.74 
2.68 
8.98 
- 
 
 
1.21  -   2.50 
1.79  -    4.03 
3.78  -   21.36 
- 
 
 
1.65 
2.59 
8.42 
 
 
1.13 - 2.41 
1.69  - 3.95 
3.52  - 20.15 
Employment status:  
Employed 
Unemployed 
Student 
Other 
Missing 
 
1 
0.89 
0.34 
- 
1.22 
 
 
0.68  -  1.18 
0.13   - 0.88 
- 
0.83  -   1.80 
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3.3.2.2 Univariate and multivariable analysis for males 
In table 3.5 there were no associations with ano-genital warts occurrence observed in both 
univariate and multivariate analysis for scabies, herpes simplex 2, syphilis, ART status, CD4 
count, age and employment status amongst males in this study group. Significant associations 
were observed between ART status and ano-genital warts occurrence, OR 1.62(1.08 – 2.45). 
Several models were used and compared to find the model that fit the data best using the 
likelihood ratio test. The model that was best was a reduced model with variables ART status 
and age. This model was tested for errors using the linktest and the Hosmer-Lemeshow test 
for goodness of fit. The yielded Hosmer-Lemeshow test a large p value of 0.74. Both test 
indicated the model fit the data well. 
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Table 3-5 Results of Univariate and Multivariable analysis for males 
Explanatory variable Crude OR   95% CI Adjusted 
OR 
95% CI 
Viral herpes         1.84 0.88  -    3.84   
Syphilis 2.00 0.26  -   15.16   
CD4 count   0.80 0.55  -  1.16   
ART status  1.60 1.07   -  2.41 1.62 1.08 – 2.45** 
Age categories:  
16 - 25 
26- 35 
36- 45 
46- 55 
>55 
 
1 
1.32 
1.43 
2.90 
6.56 
 
 
0.52  -  3.39 
0.56  -  3.64 
0.93  -  9.05 
0.76  -  56.96 
 
 
 
1.4 
1.52 
3.08 
6.77 
 
 
0.55  -  3.66 
0.60  -  3.9 
0.99  - 9.6 
0.78  -  58.86 
Employment status:  
Employed 
Unemployed 
Student 
Other 
Missing 
 
1 
0.94 
- 
- 
1.56 
 
 
0.63  -  1.40 
- 
- 
0.87  -  2.80 
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4 DISCUSSION  
 
In this section the findings of this study and how they compare to existing literature as well 
as the limitations of the study are discussed. 
4.1 Prevalence of Anogenital Warts 
More women patronized the clinic during the study period when compared to men. This is in 
line with the fact that most women will seek treatment when not well. Most men generally do 
not seek treatment unless if they are very ill (1). This study found ano-genital warts to be 
more prevalent among females than among males. Prevalence was found to be 4% in women.  
This figure concurs with the findings of a study by Low et al, which found prevalence of ano-
genital warts among women in Burkina Faso to be 3.5% (2). Banura et al found the 
prevalence of ano-genital warts among sex workers and women with STIs to range from 0.2 
to 14% in Central and South African regions in a systematic review (10). Our findings fall 
within this range. According to the South African National Strategic Plan (2012 – 2016) (32), 
sex workers are counted among high risk populations which refer to those at high risk of 
exposure as well as transmission of HIV. Risk of exposure to and transmission of other STIs 
is also higher because of multiple sex partners thus prevalence is expected to be higher in this 
group. 
Our study showed prevalence among men to be 3%. In men the systematic review by Banura 
et al found the prevalence to range from 4.8% to 50.5%. Our prevalence of 3% falls below 
that generally found in central and South African regions for men. The studies evaluated in 
the systematic review reported on men attending sexual health clinics or having reported 
Name: Qinisile Sibanda         Student Number: 535739 
 
 
 
 32 
STIs (10).  Another recent study by Darwich et al found the prevalence of genital warts in 
HIV infected men having sex with men (MSM) to be 28% and 15% in heterosexual HIV 
positive men (33). This study was conducted on patients on the Can-Ruti HIV positive men 
cohort (33). These men were outpatients receiving HIV care and management in the 
University Hospital Germans Trias I Pujol, Badalona, Spain clinics. The vast difference in 
these findings could be explained in part by the differences in data collection, literature 
suggests that prevalence of ano-genital warts does depend in part on study methodology (11). 
In our study there was no active screening for the presence of ano-genital warts. Secondary 
data not collected for purposes of this study was used. However in the study by Darwich 
there was active screening for ano-genital warts presence and thus more patients could have 
been identified. Also the population studied consisted of a high percentage of men having sex 
with men (MSM), 74% (28). In this population the occurrence of ano-genital warts and other 
sexually transmitted illnesses is known to be high (34).   
While prevalence was generally higher in females than males overall it was found to be 
higher in males above the age of 45 than in females of the same age group. This could be 
possibly because men remain sexually active longer into their old age than females. Also 
more males are found having sexual relations with younger women (<25) as they become 
older and this age group has the highest prevalence of ano-genital warts (1, 11, 22). 
Prevalence of ano-genital warts decreased with increasing age in both men and women. It 
was highest in both men and women between the ages of 16 and 25. The prevalence in 
females in this age group was 7.56% and among males it was 4.27%. This is consistent with 
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what has been found in literature which states that prevalence is highest among sexually 
active women aged below 25 (1, 11, 22). 
4.2 Factors associated with ano-genital warts 
 
  
There was a strong association between age and the occurrence of ano-genital warts among 
females. This association became stronger with increasing age group at 95 % CI.  Older age 
has been specifically found to be associated with recurrence of genital warts (16). However 
in this study it was not established whether this first occurrence during the study period was a 
recurrence or not.  
In men, being on ART showed a weak association with the occurrence of ano-genital warts 
however among females ART status was not associated with the occurrence of ano-genital 
warts. The incidence of HPV related infections has not reduced substantially in the post ART 
era (35) and the effect of antiretroviral treatment on these infections still remains uncertain 
(2). 
 There was no association of CD4 count with ano-genital warts occurrence established 
among males. Consistent with our study findings, CD4 count was not found to be a risk 
factor in men in the systematic review by Banura et al. However among females there was an 
association between CD4 count and ano-genital warts occurrence. Low CD4 count ≤ 200 
cells/m3 has been found to be a risk factor for ano-genital warts in HIV positive females by 
other studies (10, 17).  
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There were no association established between ano-genital warts and other STIs evaluated in 
this study. Other studies have reported associations of ano-genital warts with other STIs 
however these associations are still poorly understood and the data uncertain (2, 17, 22). 
We could not establish any association of employment status with ano-genital warts 
occurrence and evaluated literature did not indicate employment status or education to be a 
risk factor (17).  
4.3 Study Limitations 
The data used for this study was collected for routine patient care for HIV infected patients 
and not for the purposes of this research. This data was therefore lacking in some important 
covariates which have been found to be associated with the occurrence of ano-genital warts. 
These factors include sexual history of a person, age at first sex, smoking and number of 
sexual partners among others. There was also a lot of missing data for some factors and they 
could not be used in analysis e.g.  Only half of the study participants had baseline CD4 and 
the rest were missing.  
Results of this study need also to be interpreted cautiously due to the very small number of 
study participants with the outcome of interest in the study sample, 369 out of 10 750. This 
could have compromised the results and introduced bias. 
In our study we do not know which infection occurred first between HPV infection and HIV 
infection. Thus the prevalence found in our study does not therefore indicate if there is an 
elevation of genital warts due to HIV or not when comparing to the general uninfected 
population.  
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The study was a cross-sectional study and could only evaluate prevalent cases. Incident cases 
could not be evaluated in this study because in our participants we did not establish if the 
study participants were free from ano-genital warts at the beginning of the study. We 
therefore could not establish any new cases with certainty.  
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5 CONCLUSIONS AND FUTURE WORK 
 
5.1 Conclusion 
Prevalence of genital warts was highest among the younger age groups in both males and 
females and it decreased with increasing age. Prevalence was also higher in females than 
males up to the age of 35.   Above the age of 35, prevalence was higher in males than in 
females. One of the strategic objectives of the South African government is to reduce STIs 
infection. Females between the ages of 16 to 24 are among key population in South Africa 
and there is therefore a lot of focus on them as part of managing the HIV epidemic as well as 
STIs. The South African population has seen a reduction in new HIV cases in the young 
population and more young people are delaying their sexual debut. This is a positive sign as 
it is likely to translate into the reduction of STIs including ano-genital warts among the 
young people. As things stand this prevalence indicates young people especially females are 
still getting exposed to HIV and STI infections in their teenage years.  
There was a strong association between ano-genital warts and age among females but not 
among males. A weak association was found between ART status and the occurrence of 
genital warts among males. No association with ART status was established among females. 
Although the role out of ART in South Africa has increased in coverage we are still yet to see 
any meaningful impact of ART on ano-genital warts occurrence. There was no association 
found between any of the STIs with the occurrence of genital warts among both males and 
females. Among females a weak association between CD4 count and ano-genital warts was 
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found. Employment status of an individual was not significantly associated with ano-genital 
warts occurrence in both males and females. 
5.2 Future work 
The same research can be carried using a database from an STI clinic. These clinics are more 
likely to see more patients with ano-genital warts as well as being HIV infected.  
A research into the prevalence of ano-genital warts amongst key populations in particular 
MSM, sex workers as well as females having sex with females is necessary as it has been 
established that prevalence of ano-genital warts is higher among some groups of the key 
populations (33). 
A similar research can be done as a primary research to allow for collection of information 
on other relevant covariates like, sexual history, number of life partners and age at first sex. 
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APPENDIX A: LETTER OF APPROVAL FROM WRHI 
 
RHI 
Policies and Procedures 
  Policy/SOP No: XX-XXX 
    
Title: Access to data by external parties 
 
Prepared by: 
 
Sinead Delany-Moretlwe 
 
 
 
01-OCT-
2010 
Name Signature Date 
 
Authorized 
by: 
 
Sinead Delany-Moretlwe 
on behalf of RLG 
  
24-Nov-2010 
Name Signature Date 
 
Background 
 
RHI regularly receive requests from students or partners to conduct secondary analysis on 
existing datasets or to use data from existing cohorts. A process is required to clarify the 
relationship, expectations and deliverables from these collaborations. 
 
Scope 
All technical team heads or technical specialists or other staff that have investigator 
responsibilities. 
 
Procedure 
Requests from individuals wanting to make use of data from the RHI [project name] must 
follow the following procedure: 
 
1. A written request to use the data set must be sent to [Principal Investigator Name] at the 
RHI. The request should include: 
1.1. Names of individuals who will be using the data set and their affiliations.  
1.2. A short proposal detailing the objectives of using the data, planned analysis, 
planned public distribution of results and date of finalization.  
1.3. The request will communicated with the relevant project team and/or senior 
research staff.  
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2. A consensus decision of this group, which includes the investigator and key technical 
staff on whether to grant permission for data use will be required in all cases. An RHI-
based investigator to supervise the collaboration.  This person will take responsibility for 
and manage all communication with the external party. 
3. The applicant will be asked to write up a one page document outlining the objectives, 
analysis plan, individuals involved and purpose of the analysis (ie, dissertation, peer 
review publication, etc.) and which contains the following statements of assurance: 
3.1. All references to the data either in public/verbal presentation or print credit the RHI’s 
[Name] project as the source. 
3.2. Should the applicant wish to use the data for analysis beyond the originally 
submitted proposal, a further written request will be required and the procedures 
outlined above followed. 
3.3. Persons using the data set will submit a final draft of their work to the RHI for 
comment before it is submitted for publication or public presentation.  
3.4. The authorship of the paper will be decided using internationally recognized criteria, 
and must recognize the RHI researchers appropriately, as well as the international 
researcher/s involved in the data analysis.  RHI will make the final decision about 
authorship. 
3.5. The applicant will also be required to submit a copy of the final product resulting 
from use of the data set to the identified RHI liaison person at RHI. 
3.6. The data set will not be shared, copied or provided to anyone other than the 
person/s outlined in the proposal  
4. The proposal should be presented at RLG for information 
5. Once approval has been agreed by the above group, a decision will be communicated to 
the applicant by RHI liaison.  
6. A file will be maintained for all correspondence in this regard to the project. In particular: 
6.1. Correspondence documenting the approval process as out lined in Point 2 above  
6.2. The signed agreement of the applicant (this document). 
6.3. A copy of the final product resulting from use of the data. 
7. Ideally, a paper for publication must have been produced within one year of receiving the 
data set (this means it must be submitted to a journal within one year of receipt of the 
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data). If the individual has not done so the applicant may forfeit the right to the data and 
to the topic of interest.  
Agreement 
In terms of this agreement Qinisile Sibanda will use the Ward 21 Clinic data for the 
completion of analysis and writing of a thesis entitled “Factors associated with ano-genital 
warts among HIV infected patients at a Hillbrow clinic in Gauteng South Africa” which has 
been provisionally accepted by the University of Witwatersrand. The final version of the 
thesis will be reviewed and accepted by Dr Batanayi Muzah and Mr Eustasius Musenge 
before final submission.  The data will not be used for any other publications before 
consultation with RHI. 
 
I have read and accept these conditions. 
 
Applicant:  
 
Date: 
 03/09/2012 
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